Guided Therapeutics, Inc. (OTCMKTS:GTHP) Short Interest Up 40.8% in February

Guided Therapeutics, Inc. (OTCMKTS:GTHP) was the target of a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 13,800 shares, a growth of 40.8% from the January 31st total of 9,800 shares. Based on an average trading volume of 28,200 shares, the days-to-cover ratio is presently 0.5 days.

Guided Therapeutics Stock Down 8.9 %

Shares of GTHP traded down $0.01 during midday trading on Tuesday, reaching $0.10. 28,256 shares of the stock were exchanged, compared to its average volume of 17,319. The company has a market cap of $6.25 million, a price-to-earnings ratio of -3.19 and a beta of 0.61. Guided Therapeutics has a 12-month low of $0.06 and a 12-month high of $0.23. The firm has a 50 day simple moving average of $0.13 and a 200-day simple moving average of $0.15.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.